Brochure | October 5, 2022

Comprehensive Solutions For Your Vaccine Platforms

laboratory scientist success iStock-1304127970

Vaccine production, from process development to full-scale GMP-manufacturing, must be efficient, safe, and cost-effective. Learn how our global capabilities can help you achieve these goals for all your modalities/platforms including inactivated/live attenuated vaccines, subunit vaccines, VLP vaccines, viral vector vaccines, pDNA vaccines, mRNA vaccines.

We describe a range of products most commonly used for vaccine process development and manufacturing. Because each vaccine workflow is unique, however, selection of products most appropriate for your specific workflow requires testing and confirmation through MSAT support.

Discover how expertise—empowered by collaboration—can refine and overcome manufacturing challenges in all vaccine modalities/platforms.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene